Monocyte Subset Recruitment Marker Profile Is Inversely Associated With Blood ApoA1 Levels

Vyoma K Patel1,2, Helen Williams1,2, Stephen C H Li3,4

  • 1Vascular Biology Research Centre, Department of Surgery, Westmead Hospital, Westmead, NSW, Australia.

Insights

Dyslipidemia, particularly low Apolipoprotein A1 (ApoA1) levels, increases monocyte extravasation potential. This suggests dyslipidemia may enhance monocyte recruitment in cardiovascular disease development.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Lipid Metabolism

Background:

  • Dyslipidemia is a key driver of atherosclerosis, characterized by plaque development.
  • Monocyte influx into the vessel wall is crucial for plaque progression.
  • The link between dyslipidemia and monocyte extravasation potential remains unclear.

Purpose of the Study:

  • To investigate if dyslipidemia is associated with an increased potential for monocyte extravasation.
  • To examine recruitment marker expression on monocyte subsets in relation to lipid profiles.

Main Methods:

  • Flow cytometry was used to analyze monocyte subsets from healthy individuals with varying lipid profiles.
  • Expression of recruitment markers was compared across monocyte subsets and participants.
  • Correlations between marker expression and lipid levels, specifically Apolipoprotein A1 (ApoA1), were assessed.

Main Results:

  • Monocyte subsets exhibited distinct recruitment marker expression patterns.
  • Significant inter-participant variability in marker expression was observed, overshadowing subset differences.
  • Higher expression of multiple recruitment markers correlated with lipid profiles, notably an inverse correlation with ApoA1 levels.

Conclusions:

  • Dyslipidemia, especially low ApoA1, is linked to an elevated capacity for all monocyte subsets to extravasate.
  • This extravasation involves a broader range of recruitment markers than previously recognized.
  • Findings highlight a potential mechanism linking dyslipidemia to enhanced monocyte recruitment in cardiovascular disease.